BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 8, 2013
View Archived Issues
Avagacestat studied in predementia Alzheimer's disease in phase II trial
Read More
Preclinical anticancer efficacy demonstrated for AKB-9778
Read More
Novel technique developed to reprogram iPSCs to treat hemophilia
Read More
Enteris BioPharma officially launches business and development activities
Read More
Sanofi reports highlights of second quarter 2013
Read More
Cardium files new 510(k) submission with FDA for Excellagen wound care product
Read More
Regen obtains license to ddRNAi gene silencing technology
Read More
Lee's Pharmaceutical files to perform pivotal trial of gimatecan for ovarian cancer in China
Read More
Piramal Enterprises receives IND clearance from FDA for novel DGAT1 inhibitor
Read More
Affymetrix launches OncoScan FFPE Assay Kit for degraded FFPE solid tumor samples
Read More
A small-molecule PDE7 inhibitor for the treatment of neurodegenerative disorders described
Read More
gIcare Pharma begins phase II trial of GIC-1001 in sedation-free colonic analgesia
Read More
Medeia Therapeutics presents new androgen receptor antagonists
Read More
Study to explore connection between celiac disease and type 1 diabetes begins
Read More
Athersys receives grant to advance MultiStem regenerative medicine program
Read More
Researchers at Genosco and Oscotec synthesize novel SYK inhibitors
Read More
Orexo begins dosing in two trials evaluating early and long-term treatment with Zubsolv
Read More
Chinese researchers divulge new c-Met inhibitors
Read More
Novartis phase III study of Afinitor in advanced liver cancer does not meet primary endpoint
Read More
Daiichi Sankyo designs new agents for diabetes and obesity
Read More
Japanese group reports novel FGFR inhibitors to be useful for cancer
Read More
First patient treated with Civacir after liver transplantation in phase III trial
Read More
GSK files for use of Votrient as maintenance therapy for advanced ovarian cancer in the E.U.
Read More
GSK files MAA with EMA for use of Cervarix in two-dose schedule
Read More
Rexahn begins dosing in phase I trial of Supinoxin in solid cancer tumors
Read More
Bavarian Nordic obtains European approval for Imvanex smallpox vaccine
Read More